These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 10663458

  • 1. Continued use of the proton-pump inhibitor lansoprazole following Helicobacter pylori eradication.
    Claessens AA, Heerdink ER, van Eijk JT, Lamers CB, Leufkens HG.
    Eur J Clin Pharmacol; 2000 Jan; 55(10):773-6. PubMed ID: 10663458
    [No Abstract] [Full Text] [Related]

  • 2. Suppression of Acid Secretion by Lansoprazole and its Effects on Helicobacter pylori. II. Poster presentations from the 2nd International Colloquium on Proton Pump Inhibitors. Houston, Texas, September 29, 1994.
    J Clin Gastroenterol; 1995 Jan; 20 Suppl 2():S1-135. PubMed ID: 7594319
    [No Abstract] [Full Text] [Related]

  • 3. Proceedings of the 2nd International Colloquium on Proton Pump Inhibitors.
    J Clin Gastroenterol; 1995 Jan; 20 Suppl 1():S1-51. PubMed ID: 7673606
    [No Abstract] [Full Text] [Related]

  • 4. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
    Altintas E, Sezgin O, Ulu O, Aydin O, Camdeviren H.
    World J Gastroenterol; 2004 Jun 01; 10(11):1656-8. PubMed ID: 15162544
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant therapy for Helicobacter pylori eradication: role of lansoprazole shown in vitro.
    Mégraud F.
    J Clin Gastroenterol; 1995 Jun 01; 20 Suppl 1():S24-7. PubMed ID: 7673610
    [Abstract] [Full Text] [Related]

  • 6. [Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori].
    Kawata H, Satoh K.
    Nihon Rinsho; 2002 Feb 01; 60 Suppl 2():640-4. PubMed ID: 11979862
    [No Abstract] [Full Text] [Related]

  • 7. Helicobacter pylori eradication increases nocturnal acid breakthrough.
    van Herwaarden MA, Samsom M, Smout AJ.
    Aliment Pharmacol Ther; 2000 Jul 01; 14(7):961-2. PubMed ID: 10886054
    [No Abstract] [Full Text] [Related]

  • 8. Determinants of non-response in Helicobacter pylori eradication trials.
    Klotz U, Treiber G, Schwab M.
    J Gastroenterol Hepatol; 2005 Sep 01; 20(9):1471. PubMed ID: 16105147
    [No Abstract] [Full Text] [Related]

  • 9. [Helicobacter pylori eradication: modified triple therapy with lansoprazole].
    Müller P, Simon B.
    Fortschr Med; 1996 Dec 20; 114(35-36):497-9. PubMed ID: 9119351
    [Abstract] [Full Text] [Related]

  • 10. Effect of lansoprazole on Helicobacter pylori.
    Lamouliatte H.
    Clin Ther; 1993 Dec 20; 15 Suppl B():32-6. PubMed ID: 8205593
    [Abstract] [Full Text] [Related]

  • 11. Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis.
    Zhao F, Wang J, Yang Y, Wang X, Shi R, Xu Z, Huang Z, Zhang G.
    Helicobacter; 2008 Dec 20; 13(6):532-41. PubMed ID: 19166419
    [Abstract] [Full Text] [Related]

  • 12. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T, Shirai N, Takashima M, Xiao F, Hanai H, Sugimura H, Ohashi K, Ishizaki T, Kaneko E.
    Clin Pharmacol Ther; 2001 Mar 20; 69(3):158-68. PubMed ID: 11240980
    [Abstract] [Full Text] [Related]

  • 13. Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
    Kawano S, Murakami M, Saita H, Tsuji S.
    J Gastroenterol; 1996 Nov 20; 31 Suppl 9():41-3. PubMed ID: 8959517
    [Abstract] [Full Text] [Related]

  • 14. Which proton pump inhibitor should we use?
    Williams CN.
    Can J Gastroenterol; 1997 Nov 20; 11(1):29. PubMed ID: 9113794
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication.
    Niv Y.
    Dig Dis Sci; 2005 May 20; 50(5):839-41. PubMed ID: 15906754
    [Abstract] [Full Text] [Related]

  • 16. Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients.
    Marusic M, Babic Z, Nesanovic M, Lucijanic-Mlinac M, Stajcar V.
    World J Gastroenterol; 2005 Apr 21; 11(15):2334-6. PubMed ID: 15818748
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ, Park DI, Oh SJ, Song MJ, Choi WH, Hong CH, Park JH, Kim HJ, Cho YK, Shon CI, Jeon WK, Kim BI.
    Korean J Gastroenterol; 2008 Aug 21; 52(2):80-5. PubMed ID: 19077498
    [Abstract] [Full Text] [Related]

  • 18. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
    Treiber G, Wittig J, Ammon S, Walker S, van Doorn LJ, Klotz U.
    Arch Intern Med; 2002 Jan 28; 162(2):153-60. PubMed ID: 11802748
    [Abstract] [Full Text] [Related]

  • 19. Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study.
    Gupta VK, Dhar A, Srinivasan S, Rattan A, Sharma MP.
    Am J Gastroenterol; 1997 Jul 28; 92(7):1140-2. PubMed ID: 9219786
    [Abstract] [Full Text] [Related]

  • 20. [Activity of Lansoprazole (new proton pump inhibitor) against Helicobacter pylori and its therapeutic efficacy].
    Tamura K, Murai M, Tanaka M, Kawano S.
    Nihon Rinsho; 1993 Dec 28; 51(12):3261-6. PubMed ID: 8283644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.